Application information for the Beeson Career Development Award is now available! As you may know, this program aims to sustain and promote the research careers of clinically-trained individuals who are pursuing research careers in aging. Please note that there are two separate RFAs for the K08 and K23 career tracks.
Please share this message with qualified candidates. In recent years we have seen a decline in the number of K08 applications. There may be different factors that play a role in this decline, but the funders are committed to supporting all aging-related research, and we strongly encourage qualified candidates conducting basic aging-related research to apply.
Paul B. Beeson Clinical Scientist Development Award in Aging (K08)
Application Receipt Date: October 27, 2011
The broad fields of research appropriate for this K08 announcement include research in the basic sciences including animal models of aging or the use of secondary data analyses where there is apparent clinical relevance. Other examples include but are not limited to:
- The elucidation of basic biochemical, genetic, and physiological mechanisms underlying aging and age-related changes in humans and in appropriate animal models
- Investigations focused on basic social and behavioral influences on the aging process, both at the individual and societal levels; models of transplantation in older patients; the utility and challenges of Medicare
Research on the neural and behavioral processes associated with the aging brain, including brain-behavior biomarkers and behavior in models of Alzheimer’s disease (some topics may also be appropriate for K23 RFA below)
Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23)
Application Receipt Date: October 27, 2011
For the purposes of this K23 award, Patient-Oriented Research is defined as research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: 1) mechanisms of human disease; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies.
For more information and to view the RFAs, please visit